Am ain remaining challengei np rotein engineering is how to recombine beneficial substitutions. Systematic recombinations tudies show that poorly performing variants are usually obtained after recombination of 3t o4beneficial substitutions. This limits researchers in exploiting nature's potential in generatingb etter enzymes. TheC omputer-assisted Recombination (CompassR)s trategy provides as election guide for beneficial substitutionst hat can be recombined to gradually improvee nzyme performance by analysis of the relative free energy of folding (DDG fold ). The performance of CompassR was evaluated by analysis of 84 recombinantsl ocated on 13 positions of Bacillus subtilis lipase A. The finally obtainedv ariant F17S/V54K/D64N/D91Eh ad a 2.7-fold improved specific activity in 18.3 %( v/v) 1-butyl-3methylimidazolium chloride ([BMIM][Cl]). In essence,t he de-ductedC ompassR rule allows recombination of beneficial substitutions in an iterative manner and empowers researchers to generate bettere nzymes in atime-efficient manner.
Introduction
Directed evolution of proteins has matured into ap owerful methodology to improvee nzymep roperties,s uch as stability, selectivity,a nd specific activity. [1] The Nobel Prize in chemistry in 2018 was awarded in recognitiono ft he significant impact of directed evolution on both gaining of scientific knowledge and application in chemical industries and in medicine. [2] The beauty of directedp rotein evolution is that all kinds of protein properties that can be reflected in the employeds creening/se-lections ystem, can within physical boundaries be improved without anym olecular understanding or hypothesis. [3] Subsequenta nalysis of the identified amino acid exchanges enables the discoveryo fn ew fundamentald esign principles of enzymes. The key technologiesr equired for directed evolution are diversity generation and high-throughputs creening. The diversity generation challenge is largely solved today, with the development of random and multi-site saturation mutagenesis methods. [2] For example, epPCR already generates % 10 12 variants under standarde rror-prone conditions within two to three hours. [4] Remaining challenges are how to navigate through the huge protein sequence space (numbersp roblem in screening) and how to recombine beneficial substitutions. Beneficial substitutionc ould be obtained from directede volution experiments after screening af ew thousand variants or by (semi-) rational design studies. Numerous reports pointo ut that recombining more than two or three beneficial substitutions does not necessarily yield furtheri mproved enzyme variants. [5] Additionally,t he best performing variants are often obtainedi ne arly stages of recombination, for example,a fter one or two recombined substitutions. [6, 7] Several studies also point out that beneficial substitutions drive each other to "extinction". [8] Interestingly,t he simultaneous site saturation of two sets of amino acids (each comprising five beneficialp ositions with four to five substitutions per recombined position) yielded after screening of 1500 variants af raction of only 0.67 % active clones for the phenylacetone monooxygenase (PAMO, 10 clones). [9] Comparable results were reported for the alcohol dehydrogenase (cpADH5) [7d] with af raction of 1.2 %o fa ctive clones( 4s imultaneously saturated positions, screeningo f3 500 variants). In another report, ten identified positions in limo-nene epoxide hydrolase (LEH) were simultaneouslyr ecombined using am ulti-site directed mutagenesis method( one substitution per position) and after screening of 3320c lones, 533 activev ariants were obtained. The most beneficialv ariant with inverted enantioselectivity had only three substitutions. [10] All the latter reports confirmt hat rules and methods to guide recombination experiments are limited by al ow fractiono f active recombinants that are highly desirable in the field of protein engineering for generating better performing catalysts.
How can we ensure that enzymesa re active after several iterative recombinations?S everal factors affect the enzyme activity andf unction( e.g.,s ubstrate binding, [11] product release, [12] temperature, [13] pH [14] ), however,i ti sg enerally accepted that enzymes must be able to fold stably in order to function properly. [15] The relationship between stabilitya nd function of an enzyme( referred to as stability-activity tradeoff) is well studied in respect to thermostability and catalytic activity. [16] The relative free energy of folding (DDG fold )w as employed as am easure of protein stability and to assess the relationship between stabilitya nd functioni ns everal enzymes (e.g.,TEM-1 b-lactamase, [17] cytochrome P450 BM3, [18] green fluorescentp rotein avGFP [19] and others [16c, 20] ). It is known that most proteins are marginally stable, and substitutions can be toleratedu ntil the "robustness threshold" is reached. [17b,d] The variantst hat have highers tability tend to have higherp rotein fitness [17c] and extra stabilityc ould increase evolvability to accept aw ider range of beneficial substitutions. [18] All these above studies indicate that the DDG fold is an important factor for predicting the evolvability and/or performance of proteins. In order to analyze the stabilityo fa ll the single substitutions, researchers used the reported accuracy of DDG fold predictors to bin the DDG fold into severals tabilizing/destabilizing categories. [16c] Computed DDG fold (in kcal mol À1 )o fs ingle substitutions are regarded as highly stabilizing (< À1.84), stabilizing (À1.84 to À0.92), slightly stabilizing (À0.92 to À0.46), neutral (À0.46 to + 0.46), slightly destabilizing (+ 0.46 to + 0.92), destabilizing (+ 0.92 to + 1.84), and highly destabilizing (> + 1.84). [12] Several computational protein stability predictors are availablet oc alculate DDG fold ,f or example, FoldX, [21] Rosetta, [22] CUPSAT, [23] PoPMuSiC [16b] and others. [24] Although stabilizing/destabilizing categoriesc an be applied to classify single substitutions, [16c] the thresholds of DDG fold values forr ecombination of single beneficial substitutions are still missing. We selected FoldX as it is ap opular and reliable methodf or determining changes in the free energy of folding caused by substitutions. Compared with other predictors, FoldX achieved the highestc orrelation (r = 0.96) for binned data in ar ecent evaluation [25] and has often successfully been used for identifying beneficial positions. [16c, 24, 26] Bacillus subtilis Lipase A( BSLA)i sawell-studied enzyme and was chosen to develop CompassR as ap redictorf or recombining substitutions. The "BSLA-SSM" library coversa ll the natural diversity with as ingle amino acid exchange at each position of BSLA (in total 181 positions;3 439 variants;" site-saturation mutagenesis" denoted as "SSM"). The "BSLA-SSM" library was constructed in our previous study, [27] as well as screened towards improved 1-butyl-3-methylimidazolium chloride ([BMIM][Cl]) re-sistance. CompassR wasd evelopedb ys electing 13 positions in three genes which encoded in total 39 substitutions that were recombined in as taggered extension process (StEP) library. Out of 39 substitutions, 13 beneficial substitutions( one substitution per position) were finally selected based on their DDG fold values for furtherr ecombination studies. The calculated DDG fold values of the 13 substitutions were used to place them into three categories. Three most stabilizing substitutions, F17S, V54K, andG 155P,w ere selected for two recombination campaigns ("intra-category" and "inter-category") with all other substitutions and up to four subsequent recombination experiments were performed, generating in total 84 recombinants( see Figure 2 ). Analysis of activity of the BSLA recombinantsa nd their corresponding DDG fold values was used to define the CompassR rule for recombination of beneficial substitutions.
Results
The results sectioni sd ivided into four parts to illustrate how the CompassR rule wasd eveloped.T he first part describes the resultso fs tandard recombination experiments in which 39 BLSA beneficial substitutions (39 = 3s ubstitutions 13 positions) weredistributed over three (synthetic) genes and recombined with the staggered extension process (StEP) method. [28] The analysis of the StEP recombination libraryd emonstrated that the recombination challenge applies to BSLA in as imilar manner than to reported enzymes( see Introduction;f or example, Pseudomonas aeruginosa lipase, [5] b-glucuronidase, [8b] PAMO, [9] cpADH5, [7d] LEH [10] ). The second part describes the DDG fold calculation and recombination analysis. In detail, the 13 beneficial substitutions were placed in three categories based on their DDG fold and recombined in different modes ("intra-category" and" inter-category" recombination;i nt otal 84 variants). In the third part the CompassR rule was postulated based on the obtained recombination results. In the concluding fourth part, 33 variants were analyzed in detail, and a molecular understanding of BSLA'si mproved resistance towards the ionic liquid [BMIM][Cl] is provided.
BSLA recombination by the StEP method to obtain the fraction of active population after recombination
Thirty-nine beneficials ubstitutions at 13 positions were identified in the "BSLA-SSM"l ibrary. [27] The 13 mutatedp ositions were selected thatm atch the following criteria:1 )the distance between each position was more than the minimum gap distance in the gene that can be resolved by the StEP method ( % 30 bp), [28] 2) the targeted positions were evenly distributed over on the whole bsla gene, and3 )atl east 3s ubstitutions among 19 substitutions in each selected position were beneficial. In order to enable an efficient recombination by the StEP method, [28] the 39 substitutions were distributed over three synthetic genes (three different substitutions per positions, Figure S1 and Ta ble S1 in SupportingI nformation) and recombined with the BSLA wild type ("forth" substitution per position) employing the StEP method;t he latter generatesatheo-retical diversity of 4 13 ( % 10 8 )d ifferentv ariants.T he recombination of the 13 selected positions at BSLA yielded mainly inactive variants (82 %) after screening of approximately 5000 clones.S equencing of 30 randomly chosen variants showed that all eleven active variants harbored one to three substitution(s). In detail,3had one substitution, 6h ad two,2had three ( Figure 1 , Ta ble S2 in Supporting Information). Inactive recombinants of BSLA harboredt wo to eleven substitutions. The high fraction of inactive recombinants of BSLA and the low number of substitution in active BSLA variants are well correlating with reports on the recombination challenge (see Introduction; [8b, [9] [10] ). The "best" variant obtained from the StEP-BSLA recombination experiment after screening of 5000 variants was the BSLA recombinantF 17S/V54K/Y129M with a1 .7times improved [BMIM][Cl] resistance when compared to BSLA wild type.
DDG fold calculations and analysis of intra-category and inter-category recombinations DDG fold of the selected 39 beneficial substitutions were calculated using the FoldX method. [21] As shown in Figure S2 in Supporting Information, substitutions were classified according to binned DDG fold values [16c] as follows:2 0/39 substitutions (51.3 %) were highly destabilizing (DDG fold > + 1.84 kcal mol À1 ), 8/39 substitutions (20.5 %) were slightly destabilizing (+ 0.46 < DDG fold < + 1.84 kcal mol À1 ), 9/39 substitutions (23.1 %) showed the neutrale ffect on the stability( À0.46 < DDG fold < + 0.46 kcal mol À1 ), only 2/39 substitutions (5.1 %) were stabilizing (DDG fold < À0.46 kcal mol À1 ). As the startingp oint for the Com-passR rule, 13 substitutions (one substitution per position) with the lowest to highest DDG fold (À1.49 < DDG fold < + 18.64 kcal mol À1 )w eres elected from the 39 beneficial substitutionsa nd grouped in three categories (category A-five substitutions: DDG fold from À1.49 to + 0.36 kcal mol À1 ;c ategory Bfour substitutions: DDG fold from + 1.83 to + 4.89 kcal mol À1 ; category C-four substitutions: DDG fold from + 7.52 to + 18.64 kcal mol À1 ;s ee Table 1 ).
In order to identify the threshold values of DDG fold at which BSLA variants are active or inactive,t wo recombination cam-paigns( " intra-category" and "inter-category") were performed as follows:
In the first "intra-category" campaign, substitutions among category A, category B, and category Cwere recombined. Main results in the Supporting Information show that all possible recombinantsinc ategory Ayielded active variants until recombinants with five substitutions (F17S/V54K/D64N/D91E/G155P) were obtained in round IV (see Figure S3 in Supporting Information;t welve variants had ar educed activity). In category B, except for one double substitution variant (A81E/L114E), all of the recombinants were inactive, and in categoryConly inactive variants were obtained( after already recombining two beneficial substitutions). Overall,the fraction of active recombinants was 100 %( 26/26) in category A, 13 %( 1/8) in category B, and 0% (0/6) in category C ( Ta ble S3 ). All theser esults are in agreement with the common view (see Introduction [17b-d, 18, 20a] ) that protein stability and functiono ften appear to trade off at the level of individual substitutionsa nd prove that DDG fold is an excellent predictorf or selectingb eneficial substitutions that can be recombined.
In as econd "inter-category" campaign,t hree beneficial positions of category A( F17S, V54K, and G155P) were individually recombined in three sets of experiments with all substitutions of category A, B, and Cu ntil inactiveB SLAv ariants wereo btained ( Figure S4 , S5 and S6 in Supporting Information). Figure 2s ummarizes the results from the three "inter-category" recombination campaigns with the beneficial substitutions F17S, V54K and G155P.T he comparison of the three sets of experiments showsh ighly similar trends. Recombinants within category Ay ieldedi na ll cases active variants;r ecombination within category Bl ed to unpredictabler ecombination results (few activer ecombinants with two to three substitutions; none with four substitutions) andr ecombinants within category Cw ere all inactive except one variant with ad ouble substitution.O verall, the "inter-category"r ecombination campaign with F17S ( Figure S4 ) yieldedi nc ategory A1 00 %a ctive re- combinants ( 15/15) , in category B3 3% (4/12), and in category C1 4% (1/7), respectively (Table S3 ). The "inter-category" recombination campaign with V54K ( Figure S5 ) yielded in category A1 00 %a ctive recombinants (15/15), in category B1 4% (1/7), and in category C0%( 0/7) (TableS3). The "inter-category" recombination campaign with the most stabilized substitution G155P ( Figure S6 ) yielded in category A1 00 %a ctive recombinants( 15/15), in category B1 4% (1/7), and in categoryC 0% (0/4) (Table S3 ).
CompassRrule postulation
Based on the obtained results of, in total, 84 recombinants ( Figure 2a nd Table S3 in Supporting Information) the following thresholds are postulated to place substitutions:i nc ategory A: "active recombinants" (substitutions with DDG fold + 0.36 kcal mol À1 ), in category B: "recombinants with unpredictable activity" (substitutions within + 0.36 < DDG fold < + 7.52 kcal mol À1 ), in category C: "deactivating recombinants" (DDG fold ! + 7.52 kcal mol À1 ). In summary,t he Computer-assisted Recombination (CompassR, Figure 3 ) rule guides experimentalists in how to recombineb eneficial substitutionsb ased on DDG fold value of the beneficial substitutions. CompassR expectst hat active recombinants are generated by recombining amino acid substitutions that fall into category A( DDG fold + 0.36 kcal mol À1 ). Recombinations with beneficials ubstitutions in category Cs hould be omitted and not used forr ecombinations. Re-combination with beneficial positions in category Bs houldb e considered only in the case that few beneficial substitutions are identified or useda fter recombining all beneficial substitutions from category A. Visualization of all substitutions of the best performing BLSA variant F17S/V54K/D64N/D91Ef rom categoryAshows that they are located on the surface of BSLA ( Figure S8 ). Among them, two substitutions pertain to charged amino acids (V54K, D91E) andt wo to polar ones (F17S, D64N). It is reported that the interaction of [BMIM][Cl] with the BSLA protein surface is the dominating factor that reduces BSLAa ctivity. [29] The identi- fied beneficial substitutions on the BSLA surface with changes to polar and charged residues are in accordance with these previousfindings. [29] 
Ionic liquidresistance analysis of all active recombinants

Discussion
In directede volution experiments, more than ten beneficial positions are often identified in as ingle round of directed evolution after screening of only af ew thousand variants. [30] As outlinedi nt he Introduction, methodologiesa re missing that empower researches to recombine efficientlya nd quicklym ore than three amino acids and to capitalize on identified beneficial substitutions. The recombination challenge of beneficial variantsf rom directed evolution experiments clearly represents am ain challenge that hampers the design of efficient enzymes for biocatalysis. In the presentw ork, the StEP recombination experiment (three bsla genes;each gene encoding 13 substitutions + wild type) confirmed that BSLA is not more tolerant to recombinations than many other enzymes (18 %f actiono f active clones). Active BLSA variants carried three or less amino acid substitutions (see Resultssection).
DDG fold analysiso fs ubstitutions in the StEP library indicated ac lear trend that DDG fold is ap redictor for the recombination experimentsa fter analysiso fa ctive and inactive variants. "Intra-"a nd "inter-category" recombinations by site-directed mutagenesis were performed in as tepwise manner as in previous reports. [31, 32] Based on the obtained resultso f, in total, 84 recombinants (Figure 2a nd Table S3 in Supporting Informa-tion) thresholds for recombining beneficial substitutions are postulated as the CompassR rule in the Results section. Com-passR expects that active recombinants are generatedb yr ecombining amino acids ubstitutions that fall into category A (DDG fold + 0.36 kcal mol À1 )a nd recombinations with beneficial substitutions in category Cs hould be omitted. Notably, only inactive variants were obtained for recombination experimentso fa ll beneficial substitutions in categoryC("intra-"a nd "inter-category") after recombination of three substitutions. Beneficial substitutions in category By ieldedu npredictable behavior( 7a ctive variants:2 7i nactive variants)a nd should,a t least from our point of view be considered only in cases in which few beneficial positions are identified or after recombining all beneficial substitutions from category A.
The CompassRr ule can be of high value for experimentalists enablingt hem to generate small and highly activer ecombination libraries of substitutions that fall in category A. The latter will significantly reduce experimentale fforts;f or example, 5000 StEPvariants of BSLA were screened in this study yielding the BSLA variant F17S/V54K/Y129M with a1 .7-fold ionic liquid resistance, compared to four recombined BSLA variants in category Ay ielding the BSLA variant F17S/V54K/D64N/D91Ew ith a 2.7-fold improved resistance. Interestingly,t he improved variant F17S/V54K/Y129Mf ound by the StEP recombination experiment also comprised the stabilized single substitutions (F17S and V54K), indicating that CompassR could find the substitutions obtained by StEP recombination experiment.
The CompassR rule enables the reduction of screening efforts by recombining beneficial substitutions and generating highly functional variant libraries. CompassR is based on the relative free energy of folding calculations, but differs in comparisont os equence-and structure-based computational methods( e.g.,F oldX, [21] Rosetta, [22] FireProt, [24a] MuStab, [33] I-Mutant2.0, [34] FuncLib, [35] PoPMuSiC, [16b] and others [32] )i ni ts focus on beneficialr ecombinants. The mentioned methods concentrate mostly on the prediction of the effect of individual substitutions and their effect on protein stability;n one of these methodshas been used to categorize beneficialsubstitutions and to guide recombination of beneficials ubstitutions through experimentally determined beneficial positions. It is reported that inclusion of the most stable substitution (in our case G155P) is beneficial to compensate for destabilizing substitutions. [18] In order to see if the most stabilized substitution can compensate/perform in ab etter manner than two other substitutions (F17S and V54K) as parent, aC ompassR recombination experiment with 11 recombinants was performed (Figure S6 and Table S3 ). Surprisingly,t he "most" stabilized variant G155P did not increase the number of active clones after the first recombination in category Ba nd Cc ompared to F17S and V54K. In our BSLA experiments, the CompassR results from category Ai ndicatet hat thermodynamic stability and enzymatic activity are not opposites ides of ac oin, and can jointly be improvedb yr ecombination, as shown by the stepwisei ncreased resistancea gainst the ionic liquid ([BMIM]Cl). This finding agreesw ell with the generally acceptedc oncept that function of ap rotein typically depends on its ability to fold to as ufficientlyt hermodynamically stable structure. [18] The thermody- Figure 3 . Computer-assisted Recombination (CompassR) rule for selecting beneficialsubstitutions in recombination experiments. Whens ubstitutions with DDG fold values + 0.36 kcal mol À1 are recombined one can expect active and property improvedr ecombinants (green).W hen beneficial substitutionsare recombined with DDG fold valuesr angingf rom + 0.36 to + 7.52 kcal mol À1 one cannot predictw hethert he recombinants will be inactive or active (unpredictable behavior; orange). Recombinationo fbeneficial substitutions with DDG fold ! + 7.52 kcal mol À1 results in deactivated and in activity-reduced recombinants (red). DDG fold is calculated by the FoldX method; surface representation of the BSLA (PDB ID:1 i6w,C hain A) is shown in grey.T he highlighted substitutionsi ng reen, orange, and red are the selected 13 beneficial single substitutions that wereo btained from the "BSLA-SSM" library. namic stability varies from protein to protein accordingt ot he equilibrium stability, kinetic folding/unfolding processesa nd the temperature at which assays are conducted. [36] Thereby, the exact CompassR thresholds might slightly change depending on the typeofprotein and itself fold.
CompassR differs in respect to methods based on statistical analysiso fp rotein sequence/activity relationships( e.g., ProSAR [37] and MOSAIC [38] )b ye stablishing ac orrelation between DDG fold and catalytic activity.I na ddition, CompassR could be implemented in protein engineering strategies such as KnowVolution [8d] (4 th recombination phase), CASTing, [7b] or MORPHING [39] to guide recombination of beneficial substitutions and thereby speed up the design of significantly improvede nzymes. CompassR could also be implementeda sa preselector in gene recombination experiments (e.g.,g ene shuffling [40] and StEP [28] )o rin rational-guidedm ethods like SCHEMA [41] (e.g.,t os elect beneficials ubstitutions in parents and/or introduce substitutions which can rescue non-functional chimeric proteins) or PTRec [42] by limiting the recombination process (e.g.,t hrough synthetic genes) to encoded beneficial substitutions that fall into the category A.
Conclusions
CompassR enables the design of bettere nzymes with minimal experimentale fforts through recombination of multiple beneficial substitutions that were previously identified by directed evolution and/or (semi-)rational design. The CompassR rule guides recombination of beneficial substitutions through analysis of the relative free energy of folding and an experimentally determined threshold;a ll BSLA recombinants in category A were active, and improvements gradually increased with increasingt he number of recombined beneficial substitutions. The latter is contrastt os tandard recombination methods (e.g., StEP [28] or OmniChange [43] )w hich yield active populations ranging from 0.67 %t o1 6.55 %. CompassRi st herefore of high value for experimentalists, since highly active libraries are generated and screening efforts can be minimized to af ew variants or even be omitted through gene synthesis by ordering genes that encoder ecombinants with multiple "category A" substitutions. Furthermore, the gradually increased ionic liquids resistance with increased number of substitutions (rounds of recombination) makesi tl ikely that more than five beneficial substitutions can be recombined, and much better performing enzymesc an be designedint he future.
Experimental Section Chemicals
All chemicals were of analytical grade or higher quality and purchased from Carl Roth (Karlsruhe, Germany), AppliChem (Darmstadt, Germany), and Sigma-Aldrich Chemie (Steinheim, Germany) unless specified. [BMIM][Cl] was synthesized by IoLiTec Ionic Liquids Te chnologies (Heilbronn, Germany) and was dissolved to 1.2 m by adding 18.3 %(v/v) Milli-Q water before use.
Strainsa nd plasmids
The plasmid pET22b(+ +)-bsla WT was constructed in the previous work [27] and was used as the template for the polymerase chain reactions (PCRs) performed in the present work unless specified. Chemically competent Escherichia coli DH5a and Escherichia coli BL21-Gold (DE3) (Agilent Te chnologies;S anta Clara, USA) were used as hosts for plasmids amplification and protein expression, respectively.
StEP recombination library construction and expression
The StEP library of BSLA was generated using am odified StEP PCR protocol. [28] The two-step StEP PCR protocol is shown in Ta bles S4 and S5 in Supporting Information. Three bsla genes with 13 substitutions each were synthesized by Invitrogen (Germany). The BSLA StEP library was cloned into the pET22b(+ +)v ector using the PLICing method, [43] the specific primer is listed in Ta ble S6. Then StEP recombination library was transformed and expressed in Escherichia coli BL21-Gold (DE3) using standard methods.
Site-directed mutagenesis
BSLA variants were stepwise constructed by PCR according to the QuikChange site-directed mutagenesis method, [31] using the primers listed in Ta ble S7 in Supporting Information.
Activityassay in 96-wellmicrotiter plate
The screening procedure and activity determinations with the p-nitrophenyl butyrate (pNPB) assay were performed as previously reported in 96-well MTPs. [27, 44] BSLA resistance (wild type or variant) was evaluated as activity in the presence of ionic liquid divided by activity in the absence of ionic liquid [27, 44] (Infinite M200 PRO microtiter plate reader;T ecan, Maennedorf, Switzerland). Residual activity and background of an empty vector were determined and subtracted in all analysis. All data shown were at least measured in triplicates.
Computational procedures
The relative folding free energies (DDG fold = DG fold,sub ÀDG fold,wt ) were computed using FoldX version 3b5.1 [21] employing the YASARA Plugin [45] in YASARA Structure version 13.9.8. [46] The initial structure of the BSLA for analysis was taken from the BSLA crystal structure (PDB ID:1 i6w [47] Chain A, resolution 1.5 ). Default FoldX parameters were used for temperature (298 K), ionic strength (0.05 m), and pH (7). The structure of the BSLA wild type was rotamerized and energy minimized using the "RepairObject" command to correct the residues that have non-standard torsion angles. Five FoldX runs were performed for each substitution to ensure that the minimum energy conformation of even large residues that possess many rotamers is identified. The accuracy of FoldX method in prediction of relative folding free energies is reported to be 0.46 kcal mol À1 (the standard deviation of the difference between DDG fold calculated by FoldX and the experimental values). [21] PyMOL [48] was used to visualize the BSLA structure. and Prof. Dr.L eilei Zhu for discussions. Calculations were performed with computing resources granted by JARA-HPC from RWTH Aachen Universityu nder projectsJARA0169.
